Abstract
398 - The oligoclonal anti-EGFR antibody MM-151 synergizes with trametinib in KRAS wildtype and mutant colorectal cancer models resistant to conventional monoclonal anti-EGFR antibodies
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have